Related Experiment Videos
[The indications for the Valtrac-ring--Report on 1015 Anastomoses]
1Chirurgische Klinik, Krankenhaus Altstadt des Städtischen Klinikums Magdeburg, Germany.
Zentralblatt Fur Chirurgie
|January 24, 2002
Summary
The Valtrac anastomosis device demonstrated a low overall insufficiency rate of 1.1% across 1,015 procedures. However, rates varied significantly between upper (0.4%) and lower (4.2%) gastrointestinal tract surgeries.
Area of Science:
- Gastrointestinal Surgery
- Surgical Devices
- Clinical Outcomes
Background:
- The Valtrac anastomosis device has been utilized in various gastrointestinal surgical procedures.
- Evaluating the efficacy and safety of surgical anastomosis techniques is crucial for patient outcomes.
Purpose of the Study:
- To assess the anastomosis insufficiency rate of the Valtrac device in a large patient cohort.
- To identify specific gastrointestinal tract locations where Valtrac anastomosis is most effective and where it may be less indicated.
Main Methods:
- Prospective data collection of 1,015 Valtrac-anastomoses performed in 876 patients over a 10-year period (June 1991-June 2000).
- Analysis of patient demographics, disease types (malignant vs. benign), and anastomosis insufficiency rates.
- Stratification of insufficiency rates based on the location within the upper and lower gastrointestinal tract.
Main Results:
- An overall anastomosis insufficiency rate of 1.1% per anastomosis and 1.3% per patient was observed.
- A significant difference in insufficiency rates was found between the upper gastrointestinal tract (0.4%) and the lower gastrointestinal tract (4.2%).
- The Valtrac device showed promise in specific applications including intrathoracic oesophagogastrostomy, gastrostomy for pyloric stenosis, and small bowel Y-Roux reconstructions.
Conclusions:
- The Valtrac anastomosis device is associated with a low insufficiency rate, particularly in the upper gastrointestinal tract.
- Routine use of Valtrac anastomosis is not recommended for oesophagojejunostomy after gastrectomy or colorectal anastomosis after rectum resection due to higher insufficiency rates.
- Valtrac is recommended for specific indications such as intrathoracic oesophagogastrostomy, gastrostomy, and small bowel reconstruction.